Factbox: CureVac's experimental coronavirus vaccine
Unlisted biotech firm CureVac on Wednesday become the second company after rival BioNTech to launch human trials of an experimental coronavirus vaccine in Germany, eyeing potential regulatory approval in mid-2021. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: vaccine, coronavirus, experimental, mid-2021, approval, regulatory, potential, eyeing, Germany, trials, human, launch, BioNTech, rival, company, second, become, CureVac, biotech, Unlisted, CureVac's, Factbox